FDA Inspection
Sombra Cosmetics, IncSombra Cosmetics, Inc – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Sombra Cosmetics, Inc, with an inspection on July 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4fc4dfc2-9c45-45f2-b94b-063d09bcbd93
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1243901
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
FDA Citations
8- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sombra Cosmetics, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | Not classified | Denver District Office | Drug Quality Assurance |
| August 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sombra Cosmetics, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.